ArticleJournal of cardiovascular echography
Age-Creatinine-Ejection Fraction Score in Infective Endocarditis: Integrated Clinical and Echocardiographic Score for Surgically and Medically Treated Patients.
Article in Journal of cardiovascular echography. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infective endocarditis (IE) is associated with high morbidity, therefore the identification of high risk patients is crucial. Age-creatinine-ejection fraction (ACEF) score is a risk stratification tool already used in different clinical settings. The aims of our study is to evaluate its ability to identify IE patients with worst prognosis. Methods: Consecutive patients hospitalized in our infectious diseases hospital for IE were retrospectively included (January 2023 - February 2025). Clinical, laboratory, echocardiographic data and ACEF score were recorded at admission. Results: One hundred forty-three patients were included. Mean age was 65±14 years (69% males). Native valve was involved in 48% and Staphylococcus aureus was responsible in 16% patients. Thirty patients died during follow up. At adjusted Cox regression model, higher ACEF score (AdjHR= 2.944; CI 1.153-7.513; p= 0.024), diabetes mellitus (AdjHR= 4.842; CI 1.017-4.322; p 0.022), cardiac surgery indicated but not performed (AdjHR 5.695; CI 1.503-21.574; p= 0.010) and Staphylococcus aureus infection (AdjHR 1.058; CI 1.012-1.280; p <0.001) were associated with worst outcome. In Kaplan-Meier analysis, these populations had significantly higher in-hospital and early mortality (P-log-rank= 0.024; 0.022; 0.010 and <0.001). Conclusions: ACEF score is a simple risk score, integrating clinical and echocardiographic informations, that can be easily calculated in IE. High ACEF score ≥1.30 was associated to worst prognosis in terms of higher mortality during follow up, in both surgically or medically treated subjects. Our results suggest the possible use of ACEF score to stratify risk in newly diagnosed IE, representing a quick tool for clinicians in everyday practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.